Nordic Nanovector sees interest in its Non-Hodgkin Lymphoma treatment

Norwegian biotech newcomer Nordic Nanovector (NANOV.OL), which seeks ways to treat blood-related cancers, says other companies are showing interest in buying the firm. More »